Middle East and Africa Oligonucleotide Synthesis Market

Middle East & Africa Oligonucleotide Synthesis Market Size (2024 to 2029)

The Middle East & Africa Oligonucleotide Synthesis Market is expected to garner a considerable compound annual growth rate in the outlook period of 2024 to 2029.

MARKET DRIVERS AND RESTRAINTS

The Middle East and Africa are becoming increasingly popular hubs for various production industries and construction and the growth of Oligonucleotide market is growing primarily because of the various research and development activities taking part in the MEA nations.

Synthesized oligonucleotides have various applications in the life sciences, pharmaceuticals, and probing of DNA synthesis and sequencing.
Clinical trials involving humans are also becoming increasingly popular in the Middle East and African region, which triggered a demand for the Oligonucleotide industry. Gene editing, drug recovery, data storage, and synthetic biology are a few sectors in which oligos are used, thus the development of these sectors has led to the growth of the oligonucleotide synthesis industry in this area.

Covid-19 had a measurable impact on all end-users, including the construction and production segments, halting all production activities. In addition, the oligonucleotide synthesis procedure is relatively expensive. This cost ineffectiveness is also acting as a serious threat that hinders business expansion in the MEA.

On top of this, the healthcare sector is not as robust in the Middle East and African region as compared to North America or Europe, therefore in this respect, the oligonucleotide industry lags behind.

Impact of COVID-19 on the Middle East and African Oligonucleotide Synthesis Market

The Middle East and African region is one of the least affected regions by the pandemic directly, however, vicariously the region has been affected due to the decrease in investment in other sectors. Surprisingly, the oligonucleotide synthesis market saw a substantial increase in demand and production. This is majorly due to the fact that the life science and pharmaceutical industries saw a surge in demand during the foreseen period. On top of this, a lot of investments were made into research and development of the healthcare sector and vaccine. With more urbanization in African countries, we can expect a surge in healthcare industries which will in turn benefit the MEA oligonucleotide synthesis market.

This research report on the Middle East & Africa Oligonucleotide Synthesis market has been segmented and sub-segmented into the following categories.

Middle East & Africa Oligonucleotide Synthesis Market By Product

• Primers
• Probes
• Linkers
• Adaptors
• Custom
• Reagent
• Equipment

Middle East & Africa Oligonucleotide Synthesis Market By Application

• DNA
• PCR
• RNAi
• Research
• Therapeutics

Middle East & Africa Oligonucleotide Synthesis Market By End-Use

• Biotechnology
• Pharmaceutical
• Academic
• Hospital and Lifesciences

The oligos are used as microarray or gene panels which proves to be helpful in hybridization and proves to be useful in therapeutic applications.

Oligonucleotide synthesis found a wide range of applications in the medical sector for research purposes such as DNA synthesis probes and sequencing. Probes are used for the detection of complementary RNA and DNA through hybridization in clinical developments and the synthesis of artificial genes.

KEY MARKET PLAYERS

Agilent Technologies, Inc., Quintara Biosciences, Twist Bioscience, Bio-Synthesis Inc., Eurofins Genomics, Kaneka Eurogentec S.A., General Electric are some of the notable companies in the Middle East and African Oligonucleotide Synthesis market.